The formation of a camalexin biosynthetic metabolon by Mucha, S, Heinzlmeir, S, Kriechbaumer, V, Strickland, B, Kirchhelle, C, Choudhary, M, Kowalski, N, Eichmann, R, Hueckelhoven, R, Grill, E, Kuster, B, Glawischnig, E

Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib by Montenegro, RC, Howarth, A, Ceroni, A, Fedele, V, Farran, B, Pantoja Mesquita, F, Frejno, M, Berger, B-T, Heinzlmeir, S, Sailem, HZ, Tesch, R, Ebner, D, Knapp, S, Burbano, R, Kuster, B, Müller, S

Pharmacoproteomic characterisation of human colon and rectal cancer by Frejno, M, Zenezini Chiozzi, R, Wilhelm, M, Koch, H, Zheng, R, Klaeger, S, Ruprecht, B, Meng, C, Kramer, K, Jarzab, A, Heinzlmeir, S, Johnstone, E, Domingo, E, Kerr, D, Jesinghaus, M, Slotta-Huspenina, J, Weichert, W, Knapp, S, Feller, S, Kuster, B

Pharmacoproteomic characterisation of human colon and rectal cancer by Martin Frejno, Riccardo Zenezini Chiozzi, Mathias Wilhelm, Heiner Koch, Runsheng Zheng, Susan Klaeger, Benjamin Ruprecht, Chen Meng, Karl Kramer, Anna Jarzab, Stephanie Heinzlmeir, Elaine Johnstone, Enric Domingo, David Kerr, Moritz Jesinghaus, Julia Slotta‐Huspenina, Wilko Weichert, Stefan Knapp, Stephan M Feller, Bernhard Kuster

Get full text